 A Phase IV, Open Label, Randomized, Two-way Crossover, Single Dose Study to Determine Relative Bioavailability of Alprazolam 0,75mgml laboratórios Pfizer Ltda in the Oral Solution-drops Form, Versus Frontal 0,25mg laboratórios Pfizer Ltda, in the Tablets Form, Under Fasted Conditions in Healthy Volunteers. 